This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2020 Aug;16(8):645-650.

doi: 10.1080/17425255.2020.1777280. Epub 2020 Jun 20.

Soft drugs: design principles, success stories, and future perspectives

Peter Buchwald¹

Affiliations

PMID: 32476535
DOI: 10.1080/17425255.2020.1777280

Editorial

Soft drugs: design principles, success stories, and future perspectives

Peter Buchwald. Expert Opin Drug Metab Toxicol. 2020 Aug.

. 2020 Aug;16(8):645-650.

doi: 10.1080/17425255.2020.1777280. Epub 2020 Jun 20.

Author

Peter Buchwald¹

Affiliation

¹ Diabetes Research Institute and Department of Molecular and Cellular Pharmacology, Miller School of Medicine, University of Miami , Miami, FL, USA.

PMID: 32476535
DOI: 10.1080/17425255.2020.1777280

No abstract available

Keywords: Antedrug; drug metabolism; esterases; methylphenidate; prodrug; sofpironium; therapeutic index; toxic metabolite.

PubMed Disclaimer

Similar articles

[Development and clinical success of novel soft drugs].
Bodor M. Bodor M. Orv Hetil. 2020 Mar;161(10):363-373. doi: 10.1556/650.2020.31657. Orv Hetil. 2020. PMID: 32115992 Hungarian.
Drug targeting by retrometabolic design: soft drugs and chemical delivery systems.
Bodor N, Buchwald P. Bodor N, et al. J Recept Signal Transduct Res. 2001 May-Aug;21(2-3):287-310. doi: 10.1081/rrs-100107431. J Recept Signal Transduct Res. 2001. PMID: 11757686 Review. No abstract available.
Designing safer (soft) drugs by avoiding the formation of toxic and oxidative metabolites.
Bodor N, Buchwald P. Bodor N, et al. Mol Biotechnol. 2004 Feb;26(2):123-32. doi: 10.1385/MB:26:2:123. Mol Biotechnol. 2004. PMID: 14764938 Review.
Prodrug design of phenolic drugs.
Férriz JM, Vinsová J. Férriz JM, et al. Curr Pharm Des. 2010;16(18):2033-52. doi: 10.2174/138161210791293042. Curr Pharm Des. 2010. PMID: 20443775 Review.
Drug targeting via retrometabolic approaches.
Bodor N, Buchwald P. Bodor N, et al. Pharmacol Ther. 1997 Oct-Dec;76(1-3):1-27. Pharmacol Ther. 1997. PMID: 9535166 Review.

See all similar articles

Cited by

In Silico Neuroprotective Effects of Specific Rheum palmatum Metabolites on Parkinson's Disease Targets.
Garcia PJB, Huang SK, De Castro-Cruz KA, Leron RB, Tsai PW. Garcia PJB, et al. Int J Mol Sci. 2023 Sep 11;24(18):13929. doi: 10.3390/ijms241813929. Int J Mol Sci. 2023. PMID: 37762232 Free PMC article.
Cryptosporidium PI(4)K inhibitor EDI048 is a gut-restricted parasiticidal agent to treat paediatric enteric cryptosporidiosis.
Manjunatha UH, Lakshminarayana SB, Jumani RS, Chao AT, Young JM, Gable JE, Knapp M, Hanna I, Galarneau JR, Cantwell J, Kulkarni U, Turner M, Lu P, Darrell KH, Watson LC, Chan K, Patra D, Mamo M, Luu C, Cuellar C, Shaul J, Xiao L, Chen YB, Carney SK, Lakshman J, Osborne CS, Zambriski JA, Aziz N, Sarko C, Diagana TT. Manjunatha UH, et al. Nat Microbiol. 2024 Nov;9(11):2817-2835. doi: 10.1038/s41564-024-01810-x. Epub 2024 Oct 8. Nat Microbiol. 2024. PMID: 39379634 Free PMC article.
Comparative chemical and biological hydrolytic stability of homologous esters and isosteres.
de Souza HMR, Guedes JS, Freitas RHCN, Gelves LGV, Fokoue HH, Sant'Anna CMR, Barreiro EJ, Lima LM. de Souza HMR, et al. J Enzyme Inhib Med Chem. 2022 Dec;37(1):718-727. doi: 10.1080/14756366.2022.2027933. J Enzyme Inhib Med Chem. 2022. PMID: 35156494 Free PMC article.
Distribution- and Metabolism-Based Drug Discovery: A Potassium-Competitive Acid Blocker as a Proof of Concept.
Wang MS, Gong Y, Zhuo LS, Shi XX, Tian YG, Huang CK, Huang W, Yang GF. Wang MS, et al. Research (Wash D C). 2022 Jul 22;2022:9852518. doi: 10.34133/2022/9852518. eCollection 2022. Research (Wash D C). 2022. PMID: 35958113 Free PMC article.
Novel Concept for Super-Soft Topical Drugs: Deactivation by an Enzyme-Induced Switch into an Inactive Conformation.
Thoma G, Vangrevelinghe E, Luneau A, Piechon P, Beerli C, Zerwes HG. Thoma G, et al. ACS Med Chem Lett. 2023 May 30;14(6):841-845. doi: 10.1021/acsmedchemlett.3c00169. eCollection 2023 Jun 8. ACS Med Chem Lett. 2023. PMID: 37312861 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information